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A B S T R A C T
Iron deﬁciency anaemia is prevalent in older age, particularly after the age of 80. Serum ferritin
concentrations also decline, although there is no evidence to suggest that changes in iron stores are an
inevitable consequence of ageing. Chronic inﬂammation is a common condition in older people, making
the measurement of iron status difﬁcult, and it is likely that elevated levels of circulating hepcidin are
responsible for changes in iron metabolism that result in systemic iron depletion. Other contributory
factors are poor diet and somemedications, such as aspirin. Anaemia in older age has undesirable health
outcomes, including increased susceptibility to falling and depression. However, there are concerns
about possible adverse effects of iron supplements, either in relation to pro-inﬂammatory effects in the
gut or inappropriate tissue iron deposition. Brain iron levels are increased with age-related degenerative
diseases, but it is not known if this is the cause or a consequence of the disease, and genetic factors are
likely to play a role. In order to maintain body iron within the normal range a personalised approach is
required, taking into account all of the factors that may affect iron metabolism and the available
strategies for preventing iron deﬁciency or overload.
 2013 Elsevier Ireland Ltd. All rights reserved.1. Aim of this review
The objective of this narrative review was to summarise the
latest information on changes in iron metabolism and status in
the elderly population and consequent effects on health in
order to provide the framework for studies on iron in an EC-
funded project, NU-AGE (new dietary strategies addressing the
speciﬁc needs of the elderly population for healthy ageing in
Europe). Serum ferritin and soluble transferrin receptor will be
measured in 1250 male and female volunteers between the ages
of 65–79 y from ﬁve different European centres (UK, Italy,
France, Netherlands, and Poland). Half of the volunteers have
been randomly assigned to a one-year ‘whole diet’ intervention
centred on dietary guidelines speciﬁcally tailored for elderly
people with the aim of reducing age-related inﬂammation.
The other half have been asked to maintain their usual diet for
the year. Iron status is being measured at the beginning and
end of the intervention to determine if a reduction in
inﬂammatory status, resulting from the dietary changes, has
an impact on iron metabolism. In addition, dietary intake data
will be analysed to identify factors that explain the variance in
iron status in elderly men and women, using both cross-
sectional and longitudinal data.* Corresponding author. Tel.: +44 1603 591304.
E-mail address: s.fairweather-tait@uea.ac.uk (S.J. Fairweather-Tait).
0047-6374/$ – see front matter  2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.mad.2013.11.0052. Background
The adult humanbody contains 3–4 g of iron, approximately 70%
of which is present in haemoglobin (Hb) in red blood cells and
myoglobin in muscle. Iron is instrumental for the transport of
oxygen around the body and is an essential component of many
enzymesandcytochromeswhere itplaysa role inelectrontransport,
respiration and hormone synthesis. As a result of these multiple
functions, iron is important for physical performance, immunity,
cognitive development and function, thermoregulation, and thyroid
metabolism. The body efﬁciently recycles iron from degraded red
blood cells so the daily requirement to replace endogenous losses
fromthegastrointestinal tract, skin, hair, sweat andmenstrual blood
loss in women is relatively low, at about 1–1.5 mg/d.
Iron deﬁciency (ID) is the most common nutritional deﬁciency
disorder in the world, deﬁned as a lack of body iron stores, and
usually caused by inadequate absorption and/or excessive iron
losses. It is the result of an imbalance between iron supply and iron
requirements of the erythroid bone marrow. The next stage of
deﬁciency is iron-deﬁcient erythropoiesis, characterised by
reduced transferrin saturation. Finally, Hb concentrations fall
and hypochromic, microcytic anaemia (IDA) is observed; this
affects over 1 billion people worldwide (WHO, 2008).
3. Measurement of iron status
There are a number of biomarkers that reﬂect different aspects
of iron metabolism and can be used singly or collectively to assess
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available on the Biomarkers of Nutrition for Development (BOND)
website (www.nichd.nih.gov/global_nutrition/programs/bond).1. Bone marrow grading is the gold standard method of assessing
iron deﬁciency but is highly invasive so rarely used.2. Serum iron concentration and transferrin saturation indicate
the adequacy of the iron supply to developing red blood
cells. Serum iron is less reliable as it is subject to diurnal
rhythms and increases after the ingestion of iron-containing
foods. A transferrin saturation of<15% generally indicates iron
deﬁciency.3. Zinc protoporphyrin (ZPP). When there is an inadequate supply
of iron, zinc is incorporated into the protoporphyrin ring of the
haem structure. An elevated ZPP is characteristic of iron
deﬁcient erythropoiesis.4. Soluble serum/plasma transferrin receptor (sTfR). This binds
diferric transferrin (Tf) on the cell surface. The main source of
serum sTfR is bone marrow erythroid precursors (Flowers et al.,
1989). When intracellular iron supply is reduced, cell surface
TfR1 expression is up-regulated in order to acquire more iron,
and it is down-regulated when there is sufﬁcient iron. An
elevated sTfR is a marker of tissue ID and increased bone
marrow erythropoietic activity. The sTfR concentration
increases in parallel with the severity of iron depletion and
treatment of individuals with IDA results in a progressive fall in
sTfR values (Skikne et al., 1990).5. Serum/plasma ferritin concentration correlates closely with
body iron stores, and values of <12mg/L indicate absence of
liver iron stores. However it is an acute phase protein and is
elevated in people with infection or inﬂammation (see below).
In order to identify raised ferritin values that do not accurately
reﬂect body iron stores, C-reactive protein (CRP) or alpha-acid-
glycoprotein (AGP) are determined and if these are above the
normal cut-off, ferritin concentration is not used as a biomarker
of iron status.6. Body iron (Cook et al., 2003) is not a quantitativemeasure of iron
in the body but is a sensitive index that is useful for monitoring
changes in iron status, for example resulting from interventions.
It is the ratio of serum transferrin receptor to serum ferritin
concentration. It is a relatively new epidemiological technique
for monitoring iron status in population groups susceptible to
iron deﬁciency inwhich inﬂammation is uncommon or has been
excluded by laboratory screening.7. Hb concentration is a commonly measured biomarker but is not
a speciﬁc measure of IDA as there are other causes of anaemia
e.g. folate and B12 deﬁciency, and also the anaemia of chronic
disease. It is not sensitive as the cut-off values and normal
ranges vary according to sex, age, and ethnicity. Hypochromic
microcytic appearance of red cells in blood ﬁlm examination is
used by clinician as suggestive of iron deﬁciency but requires a
second biomarker (e.g. ferritin) to conﬁrm the diagnosis of IDA.
4. Factors that affect biomarkers of status
Hb concentration has been reported to decline with advancing
age, even in the absence of demonstrable disorders. In one report
this was calculated to be 0.53 g/L/y in men and 0.05 g/L/y in
women between the ages of 70 and 88 y (Nilsson-Ehle et al., 2000)
and in another the decline was 0.1 g/L/y in men and 0.09 g/L/y in
women between the ages of 70 and 80 y (Milman et al., 2008). The
decline appears to increase after the age of 80, particularly in men.
It has been shown that growth hormone and/or insulin-like growth
factor-1 are positively and erythropoietin negatively correlated
with Hb in elderly people (Nilsson-Ehle et al., 2005). Erythrocytes
released from the bone marrow are less functional and partiallydamaged in aged individuals and as they are less able to protect
themselves against stress this results in their early sequestration
(Gershon and Gershon, 1988).
Differences in Hb concentration and ferritin levels have been
noted between ethnicities (Patel et al., 2007). For example,
anaemia is reported to be more common amongst black American
compared to white American adults. However, there is evidence
that the Hb distribution curve is shifted towards lower values in
blacks (Perry et al., 1992) which has led to the debate about race-
speciﬁc criteria for deﬁning anaemia (Beutler and Waalen, 2006).
Cross-sectional data from the second National Health and
Nutrition Examination Survey show that serum ferritin concen-
trations increase with age until the sixth decade of life at which
time they reach a plateau (Yip, 1994). In a cross-sectional study of
441 men and women aged 60–93 y, serum ferritin concentration
was reported to be positively associated with increasing age in
women (p = 0.0223) but not in men. However, in a longitudinal
study undertaken in a sub-set of 125 people there was no
signiﬁcant change in iron stores over the 10 y monitoring period
(Garry et al., 2000), suggesting that changes in serum ferritin (and
iron stores) are not an inevitable consequence of ageing.
Chronic inﬂammation, a common condition in older people,
alters iron metabolism and haematopoiesis and can lead to
anaemia (Lee, 1983), but it is difﬁcult to determine whether or not
the cause of anaemia is insufﬁcient iron supply because indices of
iron status (notably serum iron, ferritin and transferrin) are
modiﬁed by the inﬂammatory state. It has been observed that
malnutrition, not uncommon in the elderly, can exacerbate the
effect of inﬂammation on biomarkers of iron status. Nevertheless,
it is possible to differentiate between pure iron deﬁciency anaemia,
anaemia of chronic disease, and anaemia of chronic disease with
co-existing iron deﬁciency using the sTfR and sTfR/log serum
ferritin index (Jain et al., 2010; Hanif et al., 2005). Rimon et al.
(2002) undertook tests for anaemia in consecutive patients
admitted to an acute geriatric ward who were older than 80 y.
Bone marrow examination conﬁrmed iron deﬁciency anaemia in
49 individuals but the routine laboratory tests identiﬁed only 8,
whereas the transferrin receptor-ferritin index identiﬁed 35,
demonstrating that this is a more sensitive and speciﬁc method
for diagnosing iron deﬁciency anaemia in the elderly when bone
marrow aspirates are not feasible. Karlsson et al. (2010) compared
bone marrow iron status with various biomarkers of iron status in
50 elderly patients. The sTfR assay correctly identiﬁed 87% of iron
deﬁcient individuals; the speciﬁcity was 74%.With ferritin cut-offs
of 20mg/L for men and 7mg/L for women this biomarker was 100%
speciﬁc for iron deﬁciency but only 35% sensitive. When a ferritin
cut-off point of 40 mg/L was used, the speciﬁcity fell to 88% but the
sensitivity increased to 100%. The sTfR-ferritin index with a cut-off
point of 3.0 gave a sensitivity of 100% and speciﬁcity of 43%.
Acute inﬂammation is another condition that affects iron
metabolism. Cunietti et al. (2004) monitored changes in biomark-
ers through an acute inﬂammation episode identiﬁed by raised CRP
(30 mg/L) in 39 older hospitalised patients (median age 79 y). All
haematological indicesmeasured, except forMCV and %transferrin
saturation, were rapidly disrupted by the acute inﬂammation and
followed differing time courses. ZPP and sTfR were not measured.
The effects of a short period of inﬂammation (20 d) due to
infection were similar to those observed in states of chronic
inﬂammation.
The regular intake of aspirin, a commonly used antiplatelet
agent in both primary and secondary prevention of cardiovascular
diseases, is associated with lower serum ferritin. In 916 elderly
people (aged 67–96 y) participating in the Framingham Heart
Study, those who took > 7 aspirins/week has a signiﬁcantly lower
serum ferritin (p = 0.004), and the effect was more marked in
diseased than healthy subjects (Fleming et al., 2001). The authors
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loss and possibly a cytokine-mediated effect on serum ferritin in
individuals with inﬂammation, infection or liver disease. Although
sampleswith a CRP > 6 mg/Lwere excluded, it is possible thatmild
inﬂammatory stateswere not detected due to the low sensitivity of
the CRP assay employed.
Obesity may complicate the interpretation of biomarkers of
iron status. The observed hypoferraemia of obesity may be due to
both true iron deﬁciency and inﬂammatory-mediated functional
iron deﬁciency. For example, in a cross-sectional study examining
the iron status of 234 obese adults compared with 172 non-obese
adults attending an outpatient clinic, the obese patients had a
higher prevalence of iron deﬁciency deﬁned by sTfR and serum
iron but not by ferritin (Yanoff et al., 2007). An increase in sTfRwas
reported to be associated with central obesity in men with
hyperferritinemia (Freixenet et al., 2009). Tussing-Humphreys
et al. (2010) measured serum hepcidin in obese premenopausal
women to investigate the reason for iron depletion in obesity.
They proposed that hepcidin was expressed in response to
inﬂammation rather than changes in iron status, and concluded
that the iron deﬁciency of obesity is true body iron deﬁcit caused
by a reduction in iron absorption rather than maldistribution of
iron due to inﬂammation. If this is conﬁrmed, sTfRmay serve as an
accurate biomarker of iron status in obese and overweight
individuals.
5. Dietary intake
Good food sources of iron include meat and meat products
which contain haem iron, especially red meat and offal and also
dark poultry meat; oily ﬁsh such as tuna and sardines; cereal
products such as fortiﬁed breakfast cereals; eggs; pulses; and dark
green vegetables. Vegetarians avoid meat so do not consume any
haem iron unless they eat ﬁsh; their main sources of iron are
fortiﬁed cereals, soybeans, tofu, lentils, kidney beans, chickpeas,
baked beans, dark green vegetables. Bread, potatoes and dried fruit
are also a useful source of iron. In elderly people, obtaining an
adequate supply of iron may be a challenge due to impaired
absorption, reduced food intake associated with lower physical
activity, and changes in dietary patterns that result in a more
limited diet.
There are special challenges associated with collecting dietary
information from elderly people, including fading memory and
poor eyesight. A systematic review (Ortiz-Andrellucchi et al., 2009)
selected 33 papers and categorised the studies into short-term
(<7 d) or long-term (>7 d) intakes. The quality of each validation
study was assessed using a scoring system, which provides a
measure of accuracy of the method, and hence gave some
conﬁdence to the evaluation that was undertaken. The correlations
between the different methods are summarised below, where very
good is >0.70, good is 0.51–0.70, and acceptable is 0.30–0.50. It
should be noted that the degree of correlation is dependent on the
accuracy of the two methods being assessed FFQ vs. diet history: very good
 FFQ vs. weighed record: good
 Diet history vs. estimated record: good
 Diet history vs. weighed record: good
 FFQ vs. 24-h recall: acceptable
 Videotaped assessment vs. 24-h recall: acceptable
Declining short-term memory makes the 24-h recall method
less appropriate for this age group. Diet history is a good method
but extended diet history interviews should be avoided in the very
old as they can take an excessively long time and concentration
levels may fall. Instead these should be replaced with modiﬁed(shorter) questionnaires. Similarly, FFQs with a large number of
items should be reﬁned to reduce the number of foods.
The relationship between iron intake and iron status is
complicated by variations in the efﬁciency of iron absorption,
but a systematic review of randomised clinical trials show a
positive time-dependent association between iron intake from
supplemental iron and serum ferritin (Casgrain et al., 2012).
In the Framingham Heart Study, cross-sectional data of
recognised modiﬁers of iron bioavailability were analysed in
1401 elderly men and women aged 67–95 y and positive
associations with serum ferritin were observed for haem iron,
supplemental iron, vitamin C and alcohol, whereas coffee intake
had a negative association (Fleming et al., 1998). A study in 358
elderly Danish men and women evaluating iron status and its
relationship with diet and supplement use (Milman et al., 2004)
reported a positive correlation between serum ferritin and intakes
of dietary iron (p = 0.03), meat (p = 0.013), alcohol (p < 0.001), and
BMI (in men only, p = 0.025), and a negative correlation with tea
consumption (p = 0.017), but no association between supplement
use and iron status. Although individual dietary enhancers and
inhibitors identiﬁed from single meal absorption studies (Hurrell
and Egli, 2010) may have a signiﬁcant impact on iron absorption
and hence status, it is more important to use data on iron
absorption from whole diets to predict iron status (Collings et al.,
2013).
6. Anaemia in the elderly
In the US, it has been estimated that approximately 11% of men
and 10% of women aged 65 and above are anaemic, and that these
ﬁgures double at the age of 85, with prevalence rates reaching 50–
60% in residential/nursing homes (Price et al., 2011). Although one
of the conclusions from the Framingham Heart Study, initiated in
1948–1950, with a cohort of 6000 adults living in Framingham
MA, was that free-living elderly white American eating a Western
diet are more likely to have high iron stores, not iron deﬁciency
(Fleming et al., 2001a), iron supplement use and high intakes of
vitamin C and red meat were shown to be important determinants
of iron status.
The English Longitudinal Study of Ageing, a prospective study of
3816 community-dwelling men and women (mean age
65.4  9.0 y), reported that 5.2% were anaemic, and these individuals
were older, less likely to drink alcohol, had a higher prevalence of
morbidity, higher CRP (indicating anaemia of chronic disease) and
demonstrated poorer performance on cognitive and physical function
tests (Hamer and Molloy, 2009).
Large epidemiological studies report that in 30% of older people
with anaemia the aetiology is unknown and the patient is
diagnosed as having ‘unexplained anaemia of ageing’ (Guralnik
et al., 2004). An investigation into reasons for anaemia in 190
patients aged 65 and over recruited from a haematology clinic,
reported that 12% had IDA, and half of these individuals normalised
Hb in response to therapeutic iron (Price et al., 2011). The oneswho
did not respond had malignancies (12%), renal disease (4%), or
unexplained anaemia (35%). The latter had signiﬁcantly higher
inﬂammatorymarkers (hepcidin and ferritin, but not IL-6) than the
non-anaemic controls.
7. Causes of iron deﬁciency anaemia
Anaemia in the elderlymay be caused by a number of individual
or combined factors, including poor diet, reduced efﬁciency of iron
absorption, occult blood loss, medications, and chronic disease
(Lopez-Contreras et al., 2010). Results from cross-sectional studies
measuring the prevalence of ID and IDA in elderly people are
therefore very variable.
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21–94 y, and were able to identify the underlying reason for
anaemia in 85% of patients. Diseases associatedwith bleedingwere
found in 37%, including colon cancer, gastric cancer, peptic ulcer,
hiatus hernia with linear erosions, colonic vascular ectasia, colonic
polyps and Crohn’s disease. Causes not associated with bleeding
were found in 51%, including atrophic gastritis, celiac disease, and
Helicobacter pylori. The authors concluded that gastrointestinal
diseases not associated with bleeding are frequently associated
with IDA in patients without gastrointestinal symptoms or other
potential causes of gastrointestinal bleeding. The diseases ob-
served in older patients were hiatus hernia, gastric cancer, colon
cancer, and colonic vascular ectasia.
H. pylori infection has been implicated as a risk factor for iron
deﬁciency, but this may be a strain-related effect (Yokota et al.,
2012). A study in 220 Australian men and women aged 65 y or
older reported no difference in median serum ferritin concentra-
tions (or Hb) between H. pylori infected and uninfected individuals
but serum ferritin concentrations were signiﬁcantly lower in
infected womenwho took low-dose aspirin (p = 0.04) (Kaffes et al.,
2003). The authors conclude that it may be the combination of H.
pylori infection and use of low-dose aspirin that impact on iron
stores.
Institutionalisation is another known risk factor. In 252
institutionalised elderly Spanish men and women, aged 65–96 y,
4-d weighed food records were collected and iron status
measured (Lopez-Contreras et al., 2010). The prevalence of
anaemia was 25.4% using a Hb cut-off of <130 g/L for men and
<120 g/L for women (WHO, 2001), but only 3.6% had serum
ferritin below the cut-off of 15 mg/L. There was a high prevalence
of inﬂammation/infection as illustrated by the fact that 41% of
individuals had raised CRP values (>5 mg/L), and there was a
signiﬁcant correlation between CRP and ferritin (p = 0.023) but
not with Hb. Diet was not one of the principal causes of anaemia
in their study, except for folate intake, but it appears that
infection/inﬂammationwas a key component. In another study in
Spain (Vaquero et al., 2004) in which elderly people living in
retirement homes were consuming an Atlantic-Mediterranean
diet (rich in meat products, ﬁsh, vegetables, fruit, olive oil and
dairy products, but poor in cereals), the prevalence of anaemia
was only 6.7%, but there were no measurements of infection/
inﬂammation.
8. Consequences of iron deﬁciency
Anaemia is associated with numerous health implications,
including a decline in physical performance, cognitive impairment,
increased susceptibility to falling, frailty, and mortality (reviewed
by Price et al., 2011).
A study in 1156 community-dwelling Italian people aged 65 y
and older showed a clear association between anaemia and
disability, poorer physical performance and lower muscle strength
(Penninx et al., 2004) but there is no proof of causality in cross-
sectional epidemiological studies. In a 4-y prospective study in
men (30%) and women (70%) aged 71 y and older (Penninx
et al., 2003) various physical performance testswere undertaken at
baseline and after 4 y and the individuals classiﬁed for anaemia
using Hb and MCV values. The number of volunteers who
undertook both sets of tests was 1146. At baseline 5.9% had
anaemia (Hb < 130 g/L men, <120 g/L women), and 15% had
borderline anaemia (Hb 130–140 g/L men, 120–130 g/L women).
Those with anaemia were older and performed signiﬁcantly worse
on the baseline physical performance battery. There was a
predicted fall in the physical performance score (p for trend
0.002), which was most marked in the anaemic group (p = 0.003)
followed by the borderline anaemic group (p = 0.02). The results ofthis study suggest that anaemia in old age is an independent risk
factor for decline in physical performance.
The association between serum iron status, cardiovascular
disease and all-cause mortality was examined in 336 elderly
Taiwanese men and women (aged > 65 y) living in long-term care
facilities (Hsu et al., 2013). The degree of iron deﬁciency was
deﬁned according to serum iron, but it should be noted that serum
iron is affected by inﬂammation, as commonly present in
cardiovascular disease, and it is not a good measure of iron
deﬁciency. Although there was a positive association between low
serum iron, cardiovascular disease and all-cause mortality,
causality cannot be inferred. The authors propose several
mechanisms for the link between iron deﬁciency and cardiovas-
cular disease. Firstly, iron deﬁciency is associated with cancer,
renal failure and chronic inﬂammation, which are generally
accompanied by higher mortality; an iron deﬁcient state may
reﬂect undiagnosed conditions. Secondly, iron deﬁciency may be a
surrogate marker for malnutrition, for which there is a link with
mortality. Thirdly, iron deﬁciency may promote oxidative damage,
for example, as illustrated by elevated serum malonyldialdehyde
production in iron deﬁciency anaemia (Coghetto Baccin et al.,
2009).
Mørkedal et al. (2011) assessed sex-speciﬁc associations of iron
status with ischaemic heart disease (IHD) mortality in a prospec-
tive study of 640,798 healthy Norwegian adults. Low iron status,
particularly in the early stages of follow-up, was associated with
increased risk of death from IHD, but the limited range of
biomarkers of iron status (serum iron, transferrin saturation, and
total iron binding capacity) were measured in non-fasting blood
samples, and it is possible that low iron statuswas a late sign in the
pathogenesis of IHD or that underlying disease inﬂuenced the
results.
A smaller prospective studywas undertaken in Finland inwhich
361 men and 394 women aged 65–99 y were followed for up to
10 y (Marniemi et al., 2005), Individuals in the highest tertile for
baseline serum iron had a reduced risk of acute myocardial
infarction (AMI) (RR 0.544, 95% CI 0.35, 0.88) and those in the
middle tertile had a reduced risk of stroke (RR 0.474, 95% CI 0.25,
0.89). There was an increased risk of stroke in those in the highest
tertile of serum transferrin (RR 1.67, 95% CI 1.07, 2.61), but no
effect of blood Hb on either AMI or stroke. When the relationship
with serum iron was analysed taking into account additional
coronary heart disease risk factors the RR of AMI and stroke were
still signiﬁcant (p = 0.016 and 0.047 respectively). In contrast,
however, when the relationship between nutritional status and all-
cause mortality was investigated in a prospective study of 405
community-dwelling Scottish men and women aged 75 y and
older, no association was found between iron status and mortality
(Jia et al., 2007).
Racial variation in the relationship of anaemia with mortality
and mobility disability among older adults has been observed. In a
group of 1018 black and 1583 white US adults, aged 71–82 y,
anaemia was associated with higher mortality in white but not
black people. Anaemia was signiﬁcantly associated with increased
risk of death and mobility disability in community-dwelling older
whites, whereas older blacks were not at risk of adverse events.
The authors suggest that the criteria for deﬁning anaemia may
need revising (Patel et al., 2007).
A cross-sectional study in 1875 men and women aged 65 y and
older (enrolled in the 2005 Health Survey for England) was
undertaken to examine the relationship between iron status
(deﬁned according to biochemical criteria) and symptoms of
depression (Stewart and Hirani, 2012). Anaemia (Hb < 130 g/L in
men, <120 g/L in women) was present in 10.8% of 1833 samples
analysed, low ferritin (<45 mg/L) in 21.6% of 1851 samples
analysed, moderately raised sTfR (>2.3 g/L) was present in 7.6%
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signiﬁcantly higher in participants with anaemia, low ferritin
and high sTfR, after adjustment for age, sex, social class,
multivitamin intake, smoking status and BMI, but the association
was reduced substantially after further adjustment for physical
health status (chronic illness). There was a signiﬁcant association
between higher number of depressive symptoms and lowerHb and
higher sTfR but not with ferritin, which suggests that the
association with anaemia is accounted for by physical health
status and thus may primarily reﬂect anaemia of chronic disease.
Onder et al. (2005) also found an association between anaemia and
depression in 986 older adults from the InCHIANTI study, a
prospective population-based study of community-dwelling men
and women (mean age 75 y). Anaemia was present in 15% of the
participants with depression and in 8% of the participants without
depression (p < 0.001), and the risk of anaemia progressively and
signiﬁcantly increased with severity of depression.
9. Adverse effects of iron
Concern has been expressed about potential adverse effects of
moderately elevated iron stores in middle-aged and older people
in that they may be associated with increased risk of several
chronic diseases, such as heart disease, cancer and type 2 diabetes
mellitus. Increased tissue iron stores have been implicated in risk
of diabetes mellitus and decrease in insulin sensitivity, but the
mechanism is uncertain (Sung et al., 2012). Iron has well-
described pro-oxidant effects in vitro, and may have pro-
inﬂammatory effects. For example, Sung et al. (2012) reported
that in 12,033 Korean men (mean age 41.2 y in the group with no
coronary artery calcium and 47.7 y in those with coronary artery
calcium) ferritin was independently associated with the presence
of coronary artery calcium, a biomarker of preclinical atheroscle-
rosis. Those in the highest quartile for ferritin (>257 mg/L) had a
higher score for coronary artery calcium than the lowest quartile
(<128 mg/L). However, the relationship with transferrin satura-
tion was weaker, suggesting that there may be another
contributory factor, unrelated to high iron status, e.g. inﬂamma-
tion or metabolic stress.
The explanation for the presence of high iron stores was sought
in a study of 614 elderly Americans participating in the
Framingham Heart Study. After excluding individuals with raised
CRP (>6 mg/L, n = 45), infection (diagnosed from white blood cell
count, n = 40) and other confounding factors (n = 69), 11.4% of the
remaining 460 participants were reported to have elevated iron
stores (serum ferritin > 300 mg/L in men, and >200 mg/L in
women). Dietary factors associated with high iron stores included
use of iron supplements (30 mg/d), >3 servings of fruit or fruit
juice/d, and >4 servings of red meat/week. High intakes of
wholegrain (>7 servings/week)were inversely associatedwith risk
of having high iron stores (Fleming et al., 2002).
Three prospective studies reported an association between
moderately elevated serum ferritin concentration (>200 mg/L) and
risk of acute myocardial infarction (Salonen et al., 1992;
Tuomainen et al., 1998; Klipstein-Grobusch et al., 1999), but the
association was not observed in other prospective studies
(Ma¨ntta¨ri et al., 1994; Frey and Krider, 1994; Magnusson et al.,
1994). Furthermore, in a matched, nested case–control study (252
cases and 499 controls) drawn from the Copenhagen City Heart
Study and the Copenhagen General Population Study, markers of
iron overload (high serum iron and transferrin saturation) were
associated with reduced risk of a near-term (4 y onset) myocardial
infarction; conversely there was an association between low
serum iron and transferrin saturation and increased risk of a near-
term myocardial infarction in this apparently healthy population
(Nordestgaard et al., 2010).A few early epidemiological studies indicated a weak positive
association between very high body iron levels and risk of cancer
e.g. colorectal cancer (Knekt et al., 1994), possibly related to free
radical tissue damage caused by iron released from degradation of
tissue ferritin. The UK Scientiﬁc Advisory Committee on Nutrition
has concluded that there are insufﬁcient data to reach a clear
conclusion about high iron levels and risk of cancer (Scientiﬁc
Advisory Committee on Nutrition, 2010). There may, however, be
an interaction between high body iron levels and lipids (either high
VLDL-cholesterol or low HDL-cholesterol) that promotes oxidative
stress (Mainous et al., 2005). There is emerging evidence to suggest
that luminal iron in the gut may be pro-inﬂammatory, and iron
supplements given to treat iron deﬁciency anaemia, common in
irritable bowel disease and other gut disorders associated with
faecal blood loss, may exacerbate the inﬂammatory processes by
stimulating the production of reactive oxygen species and
inﬂammatory cytokines (Weiss, 2011). The form of iron appears
to be important, for example chelated forms of iron are better
tolerated than ferrous sulphate, presumably because it generates a
lower concentration of soluble iron in the lumen (Liquori, 1993).
In healthy individuals brain iron levels increase with age
(Bartzokis et al., 1994) and abnormally high brain iron levels are
observed in age-related degenerative diseases. For example, in
Alzheimer’s Disease hippocampal iron is increased beyond levels
of non-demented controls (Pankhurst et al., 2008). The hippocam-
pus is the key region in memory function that is severely affected
in ageing and dementing disorders. Although there is no proof of a
causal relationship, the fact that elevated levels have been
observed in preclinical disease (Smith et al., 2010) has generated
the hypothesis that an accelerated trajectory of brain iron
accumulation, and the associated oxidative damage, may occur
during the transition from healthy ageing to dementia. Bartzokis
et al. (2011) measured hippocampal iron in healthy older people
(aged 55–76 y) of mixed racial origin and found that in men, but
not women, there was a signiﬁcant decrease in memory function
with increase hippocampal ferritin iron (p = 0.003), and indepen-
dent of gender, worse verbal working memory performance was
associated with higher basal ganglia iron (p = 0.005) in individuals
without the H63D and TfC2 gene variants. The authors suggest a
combination of genetic and MTI biomarkers may be useful for
identifying high risk groups for primary prevention clinical trials.
10. Iron requirements in the elderly
Although physiological iron requirements do not differ between
adult and elderly men and post-menopausal and elderly women
there is growing evidence that iron metabolism is affected by the
ageing process. Chronic low-grade inﬂammation leads to less
efﬁcient absorption through hepcidin regulation. Identifying iron
deﬁciency becomes more of a problem because of age-related
changes in Hb, effects of medication prescribed for age-related
disorders and diseases, and increased ferritin concentrations
associated with inﬂammatory states. The sTfR-ferritin index
appears to be the most useful method for detecting iron deﬁciency
in older people. There is sufﬁcient evidence linking iron deﬁciency
with adverse health effects to justify correcting it through diet or
iron therapy, but at the same time it is important to ensure that the
risk of high body iron stores is not increased as this may have
detrimental effects on the brain.
11. Future work
One of the most challenging problems with studies of iron
metabolism in older people ismeasuring iron status in the presence
of inﬂammatory conditions, such as obesity and age-related chronic
and degenerative diseases. Therefore the development of improved
S.J. Fairweather-Tait et al. /Mechanisms of Ageing and Development 136-137 (2014) 22–28 27biomarkers of iron status must be given high priority. This would
enable the relationships between anaemia and iron deﬁciency and
chronic diseases to be characterised more accurately and causality
clariﬁed, and would also facilitate research on the potential links
between iron and dementia. There is still some uncertainty about
iron requirements in the elderly, confounded by effects of
inﬂammation on iron status, which better biomarkers would help
address. Finally, there is virtually no information about how ageing
of the GI tract affects iron absorption, and this is urgently required
for calculating average requirements for iron (using the factorial
method) to derive dietary reference values and develop dietary
recommendations for elderly populations.
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